{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:08:14Z","timestamp":1788286094128,"version":"build-2803163510"},"reference-count":26,"publisher":"American Association for Cancer Research (AACR)","issue":"21","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Esophageal squamous cell carcinoma (ESCC) is increasing in incidence, but the knowledge of the genetic underpinnings of this disease remains limited. In this study, we identified the tetraspanin cell surface receptor uroplakin 1A (UPK1A) as a candidate tumor suppressor gene (TSG), and we investigated its function and mechanism in ESCC cells. UPK1A downregulation occurred in 68% of primary ESCCs examined, where it was correlated significantly with promoter hypermethylation (P &amp;lt; 0.05). Ectopic expression of UPK1A in ESCC cells inhibited cell proliferation, clonogenicity, cell motility, and tumor formation in nude mice. Mechanistic investigations suggested that these effects may be mediated by inhibiting nuclear translocation of \u03b2-catenin and inactivation of its downstream targets, including cyclin-D1, c-jun, c-myc, and matrix metalloproteinase 7 (MMP7). Cell cycle arrest elicited by UPK1A at the G1-S checkpoint was associated with downregulation of cyclin D1 and cyclin-dependent kinase 4, whereas metastasis suppression was associated with reduction of MMP7. These findings were consistent with evidence derived from clinical samples, where UPK1A downregulation was correlated with lymph node metastasis (P = 0.009), stage (P = 0.015), and overall survival (P &amp;lt; 0.0001). Indeed, multivariate cyclooxygenase regression analysis showed that UPK1A was an independent prognostic factor for overall survival. Taken together, our findings define a function for UPK1A as an important TSG in ESCC development. Cancer Res; 70(21); 8832\u201341. \u00a92010 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-0779","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T22:31:06Z","timestamp":1288132266000},"page":"8832-8841","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Characterization of a Candidate Tumor Suppressor Gene Uroplakin 1A in Esophageal Squamous Cell Carcinoma"],"prefix":"10.1158","volume":"70","author":[{"given":"Kar Lok","family":"Kong","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora L.","family":"Kwong","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim Hon Man","family":"Chan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Chen","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Liu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Bi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ru","family":"Qin","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Ying Kit","family":"Law","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yuan","family":"Guan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"},{"name":"Authors' Affiliations:\u20081Department of Clinical Oncology and Center for Cancer Research and 2Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong; 3State Key Laboratory of Oncology in Southern China, Cancer Center and 4Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; and 5Department of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2010,10,31]]},"reference":[{"key":"2022061702403947200_bib1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ijc.2910550604","article-title":"Estimates of the worldwide mortality from eighteen major cancers in 1985: implications for prevention and projections of future burden","volume":"55","author":"Pisani","year":"1993","journal-title":"Int J Cancer"},{"key":"2022061702403947200_bib2","first-page":"113","article-title":"Epidemiology of esophageal cancer in China","volume":"162","author":"Li","year":"1982","journal-title":"Natl Cancer Inst Monogr"},{"key":"2022061702403947200_bib3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0959-8049(01)00267-2","article-title":"Cancer burden in the year 2000. The global picture","volume":"37","author":"Parkin","year":"2001","journal-title":"Eur J Cancer"},{"key":"2022061702403947200_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ijc.10706","article-title":"Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90","volume":"102","author":"Ke","year":"2002","journal-title":"Int J Cancer"},{"key":"2022061702403947200_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/302970","article-title":"Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China","volume":"67","author":"Zhang","year":"2000","journal-title":"Am J Hum Genet"},{"key":"2022061702403947200_bib6","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0021-9258(17)42095-3","article-title":"Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane","volume":"269","author":"Lin","year":"1994","journal-title":"J Biol Chem"},{"key":"2022061702403947200_bib7","doi-asserted-by":"crossref","first-page":"19170","DOI":"10.1016\/S0021-9258(17)30640-3","article-title":"Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation","volume":"265","author":"Wu","year":"1990","journal-title":"J Biol Chem"},{"key":"2022061702403947200_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1242\/jcs.106.1.31","article-title":"Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein","volume":"106","author":"Wu","year":"1993","journal-title":"J Cell Sci"},{"key":"2022061702403947200_bib9","doi-asserted-by":"crossref","first-page":"29752","DOI":"10.1074\/jbc.270.50.29752","article-title":"Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells","volume":"270","author":"Wu","year":"1995","journal-title":"J Biol Chem"},{"key":"2022061702403947200_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/bj3550013","article-title":"Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition","volume":"355","author":"Liang","year":"2001","journal-title":"Biochem J"},{"key":"2022061702403947200_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1096\/fasebj.11.6.9194523","article-title":"The tetraspanin superfamily: molecular facilitators","volume":"11","author":"Maecker","year":"1997","journal-title":"FASEB J"},{"key":"2022061702403947200_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.1252","article-title":"Uroplakin gene expression in normal human tissues and locally advanced bladder cancer","volume":"199","author":"Olsburgh","year":"2003","journal-title":"J Pathol"},{"key":"2022061702403947200_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/019262339902700606","article-title":"Comparison of uroplakin expression during urothelial carcinogenesis induced by N-dButyl-B-(4_hydroxybutyl)Nitrosamine in rats and mice","volume":"27","author":"Ogawa","year":"1999","journal-title":"Toxicol Pathol"},{"key":"2022061702403947200_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C","article-title":"Characterization of 21 newly established esophageal cancer cell lines","volume":"69","author":"Shimada","year":"1992","journal-title":"Cancer"},{"key":"2022061702403947200_bib15","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1158\/0008-5472.CAN-07-2411","article-title":"Characterization of a novel tumor-suppressor gene PLC\u03b41 at 3p22 in esophageal squamous cell carcinoma","volume":"67","author":"Fu","year":"2007","journal-title":"Cancer Res"},{"key":"2022061702403947200_bib16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.11514","article-title":"Heterogeneous expression and association of \u03b2-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray","volume":"107","author":"Xie","year":"2003","journal-title":"Int J Cancer"},{"key":"2022061702403947200_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"2022061702403947200_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bbaexp.2005.04.004","article-title":"Transcriptional control of the human urothelial-specific gene, uroplakin Ia","volume":"1729","author":"Hall","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"2022061702403947200_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1535-6108(03)00304-0","article-title":"Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of \u03b2-catenin, and enhanced tumor cell invasion","volume":"4","author":"Lu","year":"2003","journal-title":"Cancer Cell"},{"key":"2022061702403947200_bib20","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev"},{"key":"2022061702403947200_bib21","doi-asserted-by":"crossref","first-page":"17901","DOI":"10.1074\/jbc.M111635200","article-title":"Wnt signaling controls the phosphorylation status of \u03b2-catenin","volume":"277","author":"Noort","year":"2002","journal-title":"J Biol Chem"},{"key":"2022061702403947200_bib22","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1074\/jbc.M508778200","article-title":"Phosphorylation of \u03b2-catenin by cyclic AMP-dependent protein kinase","volume":"281","author":"Taurin","year":"2006","journal-title":"J Biol Chem"},{"key":"2022061702403947200_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2022061702403947200_bib24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00384-009-0725-z","article-title":"Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer","volume":"24","author":"Fang","year":"2009","journal-title":"Int J Colorectal Dis"},{"key":"2022061702403947200_bib25","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1158\/0008-5472.CAN-09-0398","article-title":"Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression","volume":"69","author":"Yue","year":"2009","journal-title":"Cancer Res"},{"key":"2022061702403947200_bib26","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1126\/science.272.5264.1023","article-title":"Binding of GSK3\u03b2 to the APC-\u03b2-catenin complex and regulation of complex assembly","volume":"272","author":"Rubinfeld","year":"1996","journal-title":"Science"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/21\/8832\/2644085\/8832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/21\/8832\/2644085\/8832.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T03:31:36Z","timestamp":1740627096000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/70\/21\/8832\/561144\/Characterization-of-a-Candidate-Tumor-Suppressor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,31]]},"references-count":26,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2010,10,31]]},"published-print":{"date-parts":[[2010,11,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-0779","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22386962","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22386959.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22386965","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22386956","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22386959","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22386956.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22386965.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22386962.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6501710","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6501710.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,31]]}}}